Elisa Espinet
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Molecular subtypes in pancreatic cancer: from academic promise to clinical reality.
Journal: Molecular cancer
Published: December 02, 2025
Epigenetic dysregulation of IRF9 drives excessive interferon signaling in COPD.
Journal: EMBO molecular medicine
Published: August 12, 2025
Leveraging the tug-of-war with genomic retroelements to enhance immunotherapy of pancreatic cancer.
Journal: Gut
Published: October 04, 2024
Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.
Journal: Nature communications
Published: March 25, 2024
Site-specific activation of the proton pump inhibitor rabeprazole by tetrathiolate zinc centres.
Journal: Nature chemistry
Published: January 31, 2024
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer.
Journal: Nature communications
Published: December 14, 2023
Compartmentalized role of xCT in supporting pancreatic tumor growth, inflammation and mood disturbance in mice.
Journal: Brain, behavior, and immunity
Published: July 07, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma.
Journal: EMBO molecular medicine
Published: May 16, 2023
Practical Considerations for Complex Tissue Dissociation for Single-Cell Transcriptomics.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 10, 2022
Last Updated: 09/26/2026